Navidea Biopharma (NAVB) Continues Due Diligence with Alseres Pharma Over Altropane License
Go back to Navidea Biopharma (NAVB) Continues Due Diligence with Alseres Pharma Over Altropane License| NAVIDEA BIOPHARMACEUTICALS, Inc. (AMEX: NAVB) | Delayed: 0.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $1.72 | |||
| Open | $0.00 | 52 Week Low | $0.26 | |||
| Day High | $0.00 | P/E | 0.00 | |||
| Day Low | $0.00 | EPS | $-0.31 | |||
| Volume | 1 | |||||
